Fulcrum Therapeutics
FULC
#8396
Rank
A$0.42 B
Marketcap
A$5.57
Share price
-0.54%
Change (1 day)
-68.11%
Change (1 year)

EPS for Fulcrum Therapeutics (FULC)

EPS in 2026 (TTM): A-$1.78

According to Fulcrum Therapeutics's latest financial reports the company's current EPS (TTM) is A-$1.83. In 2025 the company made an earnings per share (EPS) of A-$1.78 a decrease over its 2024 EPS that were of A-$0.30.

EPS history for Fulcrum Therapeutics from 2019 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.780.12%
2025A-$1.78490%
2024A-$0.30-87.34%
2023A-$2.39-36.29%
2022A-$3.758.3%
2021A-$3.46-18.51%
2020A-$4.25-31.36%
2019A-$6.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.04 11.57%๐Ÿ‡บ๐Ÿ‡ธ USA